Valeant Pharmaceuticals International Inc (NYSE:VRX)

237.53
Delayed Data
As of May 22
 +4.26 / +1.83%
Today’s Change
106.00
Today|||52-Week Range
238.49
+65.98%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Operating ActivitiesNet Income / Starting Line122.6M276.7M508.1M74.5M
 
 
 
 
 
Depreciation412.3M437.7M353.5M407.0M
 
 
 
 
 
Total Other Cash Flow34.6M-105.7M245.5M156.4M
 
 
 
 
 
Funds From Operations548.0M683.5M1.1B700.4M
 
 
 
 
 
Funds From/For Other Operating Expenses167.1M66.2M374.3M209.3M
 
 
 
 
 
Net Cash Flow - Operating Activities380.9M617.4M749.1M491.1M
 
 
 
 
 
 
InvestingIncrease In Investments-76.3M249.7K-67.8M0.00
 
 
 
 
Decrease In Investments0.000.00125.6M17.7M
 
 
 
Capital Expenditures-114.5M-39.1M-71.9M-65.8M
 
 
 
 
 
Fixed Asset Disposal1.4M1.5B-32.1M--
 
 
 
 
Net Assets From Acquisitions -70.1M-607.0M-88.8M-795.0M
 
 
 
 
 
Other Investing - Uses0.000.000.00-10.3B
 
 
Other Investing - Sources------500.0K
 
 
Net Cash Flow Investing-270.1M760.3M-203.0M-11.2B
 
 
 
 
 
 
FinancingShort Term Borrowings-3.3M122.6K-2.0M0.00
 
 
 
 
Long Term Borrowings51.4M544.8M587.2M12.0B
 
 
 
 
 
Long Term Debt Reduction-123.5M-1.6B-1.6B-1.1B
 
 
 
 
 
Net Proceeds Stock Sale3.6M3.8M5.8M1.4B
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing6.8K15.9M-511.2K18.8M
 
 
 
 
 
Other Uses - Financing86.4M16.5M10.4M28.2M
 
 
 
 
 
Net Cash Flow - Financing-158.2M-1.1B-1.0B12.3B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash1.9M-15.3M-13.3M-15.1M
 
 
 
 
 
 
Net Change In Cash-47.4M293.8M-465.8M1.6B
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account